Research statistics

Carbetocin research: publications and trials

What has been published on Carbetocin: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Carbetocin works or is safe. For what it is and what the studies found, see the Carbetocin profile.
Automated weekly refresh · data through November 1, 2026

At a glance

Publications, all years

388

Since 1979

Publications in 2026 so far

35

Through November 1, 2026

Human clinical research

44.2%

170 of 385 classified

Registered clinical trials

96

ClinicalTrials.gov

Randomized controlled trials

73

Publications reporting an RCT in people

Systematic reviews and meta-analyses

33

Preclinical studies

29.4%

82 animal · 19 in vitro · 12 computational

Records that only mention it

50

Not counted above

Status in the library: In clinical trials. 3 publications are not yet classified by study type.

What to keep in mind

  • Some completed trials have neither posted results nor a linked results publication.

Publications by year

Carbetocin publications by year and evidence

1979, Preclinical (animal, in vitro, computational): 1 of 11981, Preclinical (animal, in vitro, computational): 1 of 11982, Preclinical (animal, in vitro, computational): 1 of 11984, Preclinical (animal, in vitro, computational): 1 of 11987, Preclinical (animal, in vitro, computational): 1 of 11990, Preclinical (animal, in vitro, computational): 1 of 11991, Preclinical (animal, in vitro, computational): 3 of 31992, Human clinical research: 1 of 41992, Preclinical (animal, in vitro, computational): 3 of 41993, Human clinical research: 1 of 11997, Preclinical (animal, in vitro, computational): 1 of 11998, Human clinical research: 2 of 31998, Preclinical (animal, in vitro, computational): 1 of 31999, Human clinical research: 1 of 31999, Preclinical (animal, in vitro, computational): 1 of 31999, Other and not yet classified: 1 of 32000, Preclinical (animal, in vitro, computational): 2 of 22001, Preclinical (animal, in vitro, computational): 1 of 12004, Human clinical research: 1 of 22004, Reviews and meta-analyses: 1 of 22005, Preclinical (animal, in vitro, computational): 3 of 32006, Human clinical research: 1 of 22006, Preclinical (animal, in vitro, computational): 1 of 22007, Human clinical research: 1 of 42007, Preclinical (animal, in vitro, computational): 1 of 42007, Reviews and meta-analyses: 2 of 42008, Preclinical (animal, in vitro, computational): 2 of 42008, Reviews and meta-analyses: 1 of 42008, Other and not yet classified: 1 of 42009, Human clinical research: 4 of 102009, Preclinical (animal, in vitro, computational): 3 of 102009, Reviews and meta-analyses: 3 of 102010, Human clinical research: 2 of 92010, Preclinical (animal, in vitro, computational): 4 of 92010, Reviews and meta-analyses: 1 of 92010, Other and not yet classified: 2 of 92011, Human clinical research: 8 of 122011, Preclinical (animal, in vitro, computational): 3 of 122011, Other and not yet classified: 1 of 122012, Human clinical research: 5 of 92012, Preclinical (animal, in vitro, computational): 2 of 92012, Reviews and meta-analyses: 2 of 92013, Human clinical research: 8 of 122013, Preclinical (animal, in vitro, computational): 2 of 122013, Reviews and meta-analyses: 2 of 122014, Human clinical research: 2 of 72014, Preclinical (animal, in vitro, computational): 4 of 72014, Other and not yet classified: 1 of 72015, Human clinical research: 10 of 162015, Preclinical (animal, in vitro, computational): 5 of 162015, Reviews and meta-analyses: 1 of 162016, Human clinical research: 10 of 172016, Preclinical (animal, in vitro, computational): 5 of 172016, Reviews and meta-analyses: 2 of 172017, Human clinical research: 6 of 142017, Preclinical (animal, in vitro, computational): 5 of 142017, Reviews and meta-analyses: 1 of 142017, Other and not yet classified: 2 of 142018, Human clinical research: 11 of 272018, Preclinical (animal, in vitro, computational): 6 of 272018, Reviews and meta-analyses: 5 of 272018, Other and not yet classified: 5 of 272019, Human clinical research: 3 of 182019, Preclinical (animal, in vitro, computational): 5 of 182019, Reviews and meta-analyses: 8 of 182019, Other and not yet classified: 2 of 182020, Human clinical research: 4 of 142020, Preclinical (animal, in vitro, computational): 5 of 142020, Reviews and meta-analyses: 3 of 142020, Other and not yet classified: 2 of 142021, Human clinical research: 14 of 212021, Preclinical (animal, in vitro, computational): 4 of 212021, Reviews and meta-analyses: 2 of 212021, Other and not yet classified: 1 of 212022, Human clinical research: 6 of 262022, Preclinical (animal, in vitro, computational): 8 of 262022, Reviews and meta-analyses: 7 of 262022, Other and not yet classified: 5 of 262023, Human clinical research: 11 of 242023, Preclinical (animal, in vitro, computational): 4 of 242023, Reviews and meta-analyses: 2 of 242023, Other and not yet classified: 7 of 242024, Human clinical research: 15 of 302024, Preclinical (animal, in vitro, computational): 6 of 302024, Reviews and meta-analyses: 5 of 302024, Other and not yet classified: 4 of 302025, Human clinical research: 26 of 482025, Preclinical (animal, in vitro, computational): 10 of 482025, Reviews and meta-analyses: 6 of 482025, Other and not yet classified: 6 of 482026 (to date), Human clinical research: 17 of 352026 (to date), Preclinical (animal, in vitro, computational): 7 of 352026 (to date), Reviews and meta-analyses: 6 of 352026 (to date), Other and not yet classified: 5 of 35Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified020406019791993200620142026*
Counted PubMed publications by year of first publication. * 2026 runs to November 1, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
197901001
198101001
198201001
198401001
198701001
199001001
199103003
199213004
199310001
199701001
199821003
199911013
200002002
200101001
200410102
200503003
200611002
200711204
200802114
2009433010
201024129
2011830112
201252209
2013822012
201424017
20151051016
20161052017
2017651214
20181165527
2019358218
2020453214
20211442121
2022687526
20231142724
20241565430
202526106648
2026 (to date)1776535

Study types

Animal study82
Randomized controlled trial73
Observational human study63
Editorial, letter or other28
Review27
Other clinical trial25
Meta-analysis23
In vitro study19
Computational study12
Correction or retraction notice12
Systematic review10
Case report9
Not yet classified3
Guideline or consensus2

Research areas

From MeSH major topics. A paper can be in several areas.

Reproductive and sexual health283
Cardiovascular42
Neurological and mental health38
Musculoskeletal21
Cognitive health13
Endocrinology12
Obesity and weight management10
Tissue repair5
Antimicrobial and infectious disease4
Metabolic health3
Oncology3
Immune system2

Registered clinical trials

33 of 62 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 62 · Unknown status: 21 · Recruiting: 8 · Not yet recruiting: 4 · Terminated: 1
Early phase 1: 3 · Phase not applicable: 44 · Phase 1: 2 · Phase 1 / Phase 2: 1 · Phase 2: 1 · Phase 2 / Phase 3: 1 · Phase 3: 11 · Phase 4: 33

TrialStatusPhaseStartedResults
The Efficacy of Carbitocin in Reduction of Blood Loss During MyomectomyNCT07721623 · 900 enrolledNot yet recruitingEarly phase 12026-08—
Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority TrialNCT07636421 · 332 enrolledRecruitingPhase 42026-08—
Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum HemorrhageNCT07401524 · 120 enrolledRecruitingPhase 42026-05—
Carbetocin vs Misoprostol for Postpartum Hemorrhage PreventionNCT07353281 · 146 enrolledNot yet recruitingPhase not applicable2026-01—
Ergometrine Versus Carbetocin to Decrease Blood Loss in MyomectomyNCT07390864 · 40 enrolledRecruitingPhase not applicable2026-01—
Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin AloneNCT07318467 · 80 enrolledNot yet recruitingPhase not applicable2026-01—
Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean DeliveryNCT07187544 · 120 enrolledRecruitingPhase not applicable2025-12—
Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human MyometriumNCT06930391 · 40 enrolledRecruitingPhase not applicable2025-09—
Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian SectionNCT06946589 · 200 enrolledNot yet recruitingPhase 42025-08—
Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean DeliveryNCT06333340 · 160 enrolledRecruitingPhase not applicable2025-01—
Timing of Carbetocin Administration in Postpartum HemorrhageNCT06776926 · 200 enrolledCompletedPhase not applicable2025-01—
Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative PainNCT06692621 · 120 enrolledCompletedPhase not applicable2024-10—
Comparison of the Effect of Carbetocin Versus Oxytocin in the Prevention of Postpartum Hemorrhage After Emergency Caesarean Section in Antenatal Low-risk PatientsNCT07380529 · 300 enrolledCompletedPhase not applicable2024-10—
Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human MyometriumNCT06285409 · 32 enrolledRecruitingPhase not applicable2024-04—
OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeNCT06420297 · 168 enrolledTerminatedPhase 32024-03—
Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeNCT06173531 · 175 enrolledCompletedPhase 32023-11Posted
Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean SectionNCT06060327 · 440 enrolledCompletedPhase not applicable2023-10—
Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese WomenNCT06217354 · 150 enrolledCompletedPhase 1, Phase 22023-07—
A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy SubjectsNCT05924321 · 40 enrolledCompletedPhase 12023-05—
Carbetocin Compared To Oxytocin During Cesarean DeliveryNCT05758012 · 260 enrolledUnknown statusPhase not applicable2023-05—
Methods Decreasing Bleeding in Open MyomectomyNCT05806307 · 105 enrolledUnknown statusPhase 42023-03—
Comparison Of The Effects Of Carbetocin And Oxytocin In C-SectıonNCT05742854 · 200 enrolledUnknown statusPhase 42023-03—
Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood LossNCT05986266 · 62 enrolledCompletedPhase 12023-02—
Carbetocin in the Prevention of Primary Postpartum HaemorrhageNCT06159959 · 244 enrolledCompletedPhase not applicable2023-01—
Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean SectionNCT05664659 · 90 enrolledCompletedPhase 42022-12—
Efficacy of Four Different Treatment Regimes on Postpartum HemorrhageNCT05467462 · 300 enrolledCompletedPhase not applicable2022-08—
Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum HemorrhageNCT05479357 · 80 enrolledUnknown statusPhase not applicable2022-07—
Routine Bilateral Uterine Artery Ligation During the Cesarean Delivery of Multiple GestationNCT05670886 · 110 enrolledUnknown statusPhase not applicable2022-06—
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic TourniquetsNCT05266534 · 162 enrolledRecruitingPhase not applicable2021-12—
Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean SectionNCT05110482 · 38 enrolledUnknown statusPhase 42021-11—
Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.NCT04182360 · 30 enrolledCompletedPhase not applicable2021-10—
Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid ObesityNCT04902729 · 48 enrolledCompletedPhase not applicable2021-07—
Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-sectionNCT05083910 · 156 enrolledCompletedPhase not applicable2021-07—
Methods to Reduce Blood Loss in Abdominal MyomectomyNCT04595812 · 120 enrolledUnknown statusPhase 42020-11—
EMG for Uterotonic Efficiency EstimationNCT04201665 · 60 enrolledCompletedPhase not applicable2020-09—
Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic MyomectomyNCT04482959 · 40 enrolledCompletedPhase 42020-07—
Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal MyomectomyNCT04357015 · 153 enrolledUnknown statusPhase 42020-05—
Uterotonics for Severe PreeclampsiaNCT04756661 · 124 enrolledCompletedPhase not applicable2020-01—
the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal MyomectomyNCT04083625 · 138 enrolledCompletedPhase 42019-09—
Effects of Oxytocin and Carbetocin on Renal System in Cesarean SectionsNCT03939806 · 100 enrolledUnknown statusPhase not applicable2019-05—
Carbetocin Myocardium Trial 2014 Part 2NCT03899961 · 240 enrolledCompletedPhase 42019-04Posted
Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum HemorrhageNCT03870256 · 135 enrolledCompletedPhase not applicable2019-04—
Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum HemorrhageNCT03870503 · 135 enrolledCompletedPhase not applicable2019-04—
Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section PainNCT02642263 · 78 enrolledUnknown statusPhase 42019-02—
Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPHNCT04089176 · 120 enrolledCompletedEarly phase 12019-02—
Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean SectionNCT03777878 · 400 enrolledUnknown statusPhase not applicable2019-01—
Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal DeliveryNCT03708497 · 360 enrolledCompletedPhase not applicable2018-12—
Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean SectionNCT03710317 · 400 enrolledCompletedPhase not applicable2018-12—
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi SyndromeNCT03649477 · 130 enrolledCompletedPhase 32018-11Posted
Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2NCT03672045 · 30 enrolledCompletedPhase not applicable2018-11—

The 50 most recently started of 96 trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Carbetocin vs oxytocin for prevention of postpartum hemorrhage in women with obesity undergoing cesarean delivery: A systematic review and meta-analysis.

    Journal of gynecology obstetrics and human reproduction · May 6, 2026 · Meta-analysis · cited 0 times

    PMID 42102921 · DOI 10.1016/j.jogoh.2026.103208 · Reviews and meta-analyses

  2. Comparing oxytocin alternatives for postpartum hemorrhage prevention in vaginal and caesarean births: a systematic review and meta-analysis.

    Archives of gynecology and obstetrics · April 28, 2026 · Meta-analysis · cited 0 times · open access

    PMID 42050041 · DOI 10.1007/s00404-026-08368-5 · Reviews and meta-analyses

  3. Carbetocin in the Prevention of Postpartum Hemorrhage after Vaginal Birth: A Systematic Review and Meta-Analysis.

    Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · February 4, 2026 · Meta-analysis · cited 0 times · open access

    PMID 42483292 · DOI 10.1097/fm9.0000000000000337 · Reviews and meta-analyses

  4. Carbetocin versus oxytocin in prevention of postpartum hemorrhage after cesarean delivery in high-risk women. A systematic review and meta-analysis.

    Archives of gynecology and obstetrics · April 16, 2025 · Meta-analysis · cited 11 times · open access

    PMID 40240535 · DOI 10.1007/s00404-025-08014-6 · Reviews and meta-analyses

  5. A systematic review and meta-analysis of randomized trials comparing carbetocin to oxytocin in prevention of postpartum hemorrhage after cesarean delivery in low-risk women.

    The journal of obstetrics and gynaecology research · January 1, 2025 · Meta-analysis · cited 7 times · open access

    PMID 39722234 · DOI 10.1111/jog.16194 · Reviews and meta-analyses

  6. Uterotonics for management of retained placenta.

    The Cochrane database of systematic reviews · October 28, 2024 · Meta-analysis · cited 6 times · open access

    PMID 39465684 · DOI 10.1002/14651858.cd016147 · Reviews and meta-analyses

  7. Effect of Carbetocin on Postpartum Hemorrhage after Vaginal Delivery: A Meta-Analysis.

    Computational and mathematical methods in medicine · June 20, 2022 · Meta-analysis · cited 7 times · open access

    PMID 35770122 · DOI 10.1155/2022/6420738 · Reviews and meta-analyses

  8. Efficacy of oxytocics on reducing intraoperative blood loss during abdominal myomectomy: A systematic review and meta-analysis of randomized placebo-controlled trials.

    Journal of gynecology obstetrics and human reproduction · March 19, 2022 · Meta-analysis · cited 10 times

    PMID 35314367 · DOI 10.1016/j.jogoh.2022.102358 · Reviews and meta-analyses

  9. Effectiveness and safety of carboxytocin versus oxytocin in preventing postpartum hemorrhage: A systematic review and meta-analysis.

    The journal of obstetrics and gynaecology research · March 3, 2022 · Meta-analysis · cited 13 times

    PMID 35243717 · DOI 10.1111/jog.15174 · Reviews and meta-analyses

  10. Side-effects of carbetocin to prevent postpartum hemorrhage: A systematic review and meta-analysis of randomized controlled trials.

    Pharmacology research & perspectives · April 1, 2021 · Meta-analysis · cited 23 times · open access

    PMID 33723868 · DOI 10.1002/prp2.745 · Reviews and meta-analyses

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.

    Progress in brain research · January 1, 2008 · Review · cited 293 times

    PMID 18655903 · DOI 10.1016/s0079-6123(08)00437-8 · Reviews and meta-analyses

  2. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.

    The Cochrane database of systematic reviews · April 25, 2018 · Systematic review · cited 236 times · open access

    PMID 29693726 · DOI 10.1002/14651858.cd011689.pub2 · Reviews and meta-analyses

  3. Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth.

    The New England journal of medicine · June 27, 2018 · Randomized controlled trial · cited 210 times · open access

    PMID 29949473 · DOI 10.1056/nejmoa1805489 · Human clinical research

  4. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis.

    Stem cells (Dayton, Ohio) · June 26, 2008 · Animal study · cited 204 times

    PMID 18583541 · DOI 10.1634/stemcells.2008-0127 · Animal studies

  5. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section.

    American journal of obstetrics and gynecology · March 1, 1999 · Randomized controlled trial · cited 195 times

    PMID 10076146 · DOI 10.1016/s0002-9378(99)70271-1 · Human clinical research

Latest publications

  1. Oxytocin versus Carbetocin: Preventing Postpartum Hemorrhage in Elective C-section.

    Annals of African medicine · October 13, 2026 · Observational human study · cited 0 times

    PMID 42860922 · DOI 10.4103/aam.aam_522_26 · Human clinical research

  2. Prophylactic Carbetocin Versus Oxytocin and Blood Loss After Vaginal Delivery: Agent Selection and Confounding by Indication in a Retrospective Cohort Study.

    Medicina (Kaunas, Lithuania) · October 12, 2026 · Observational human study · cited 0 times · open access

    PMID 42942498 · DOI 10.3390/medicina62101967 · Human clinical research

  3. Uncorking Quantitative and Qualitative Seminal Traits in French-Alpine Bucks via Carbetocin Stimulation to Enhance Goat Production in Semi-Arid Environments.

    Animals : an open access journal from MDPI · October 8, 2026 · Animal study · cited 0 times · open access

    PMID 42883126 · DOI 10.3390/ani16193157 · Animal studies

  4. The Effect of Carbetocin on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled QT/QTc Study in Healthy Adults.

    Clinical and translational science · October 1, 2026 · Randomized controlled trial · cited 0 times · open access

    PMID 42802704 · DOI 10.1111/cts.70735 · Human clinical research

  5. Administering carbetocin before electroejaculation in bulls improves semen quality and increases the number of insemination doses.

    Animal reproduction science · September 4, 2026 · Other clinical trial · cited 0 times

    PMID 42705159 · DOI 10.1016/j.anireprosci.2026.108332 · Human clinical research

  6. Carbetocin versus oxytocin during elective cesarean delivery: A randomized double-blind trial.

    Pakistan journal of medical sciences · September 1, 2026 · Randomized controlled trial · cited 0 times · open access

    PMID 42819600 · DOI 10.12669/pjms.42.9.13879 · Human clinical research

  7. Untangling Mephedrone-Induced Social Reward in Rats-The Involvement of Oxytocin and Vasopressin V<sub>1A</sub> Receptors.

    Genes, brain, and behavior · August 1, 2026 · Animal study · cited 0 times · open access

    PMID 42429340 · DOI 10.1111/gbb.70057 · Animal studies

  8. Strategies for the Identification of Cyclic Peptide Drugs and Their Impurities.

    Journal of the American Society for Mass Spectrometry · August 1, 2026 · In vitro study · cited 0 times

    PMID 42463469 · DOI 10.1021/jasms.6c00023 · In vitro studies

  9. Replacing Routine Oxytocin Infusion With Single-Dose Carbetocin at Elective Caesarean Section: A Service Improvement Evaluation of Postpartum Haemorrhage Outcomes.

    Cureus · August 1, 2026 · Observational human study · cited 0 times · open access

    PMID 42677188 · DOI 10.7759/cureus.113782 · Human clinical research

  10. Carbetocin and peri-operative hemoglobin change at cesarean delivery in a setting of self-paid use: an 8-year retrospective cohort study.

    BMC pregnancy and childbirth · July 27, 2026 · Observational human study · cited 0 times

    PMID 42907989 · DOI 10.1186/s12884-026-09717-7 · Human clinical research

Browse all 388 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Carbetocin; Carbetocina; Carbetocino; Carbetocinum; Depotocin; Duratocin; Lonactene; Pabal

((TITLE_ABS:"Carbetocin" OR CHEM:"Carbetocin") OR (TITLE_ABS:"Carbetocina" OR CHEM:"Carbetocina") OR (TITLE_ABS:"Carbetocino" OR CHEM:"Carbetocino") OR (TITLE_ABS:"Carbetocinum" OR CHEM:"Carbetocinum") OR (TITLE_ABS:"Depotocin" OR CHEM:"Depotocin") OR (TITLE_ABS:"Duratocin" OR CHEM:"Duratocin") OR (TITLE_ABS:"Lonactene" OR CHEM:"Lonactene") OR (TITLE_ABS:"Pabal" OR CHEM:"Pabal")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 2). Carbetocin research statistics (Version weekly-2026-11-01) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/carbetocin